The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of Ga-68 PSMA-11 PET on management in patients with recurrent prostate cancer.
 
Tom Hope
Honoraria - GE Healthcare
Research Funding - GE Healthcare
Travel, Accommodations, Expenses - GE Healthcare
 
Rahul Raj Aggarwal
Research Funding - Novartis; Sanofi; Zenith Epigenetics
 
Kirsten L Greene
No Relationships to Disclose
 
Bryant Chee
No Relationships to Disclose
 
Dora Tao
No Relationships to Disclose
 
Felix Yi-Chung Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; GenomeDx; Medivation/Astellas
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Albert Chang
No Relationships to Disclose
 
Matthew R. Cooperberg
No Relationships to Disclose
 
Charles J. Ryan
Honoraria - Astellas Pharma; Janssen Oncology
Consulting or Advisory Role - Bayer; Millennium
Research Funding - BIND Biosciences; Karyopharm Therapeutics; Novartis
 
Eric Jay Small
Research Funding - Janssen (Inst)
 
Peter Carroll
No Relationships to Disclose